Each filer's latest filing for 83422E105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RA Capital Management, L.P.
13D/A
|
9.9% |
2/21/2025
Event 2/19/2025
|
||
| RA Capital Management, L.P. | 9.9% | |||
| Peter Kolchinsky | 9.9% | |||
| Rajeev Shah | 9.9% | |||
| RA Capital Healthcare Fund, L.P. | 9.8% | |||
|
BCLS SB Investco, LP
13D/A
|
8.8% |
3/10/2026
Event 3/6/2026
|
||
| BCLS SB Investco, LP | 0% | |||
| Bain Capital Life Sciences Fund II, L.P. | 0.3% | |||
| BCLS II Investco, LP | 8.8% | |||
| BCIP Life Sciences Associates, LP | 0.1% | |||
| BCLS II Equity Opportunities, LP | 1.0% | |||
| Bain Capital Life Sciences Opportunities IV, L.P. | 5.4% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Camber Capital Management LP
13G/A
|
0% |
2/14/2025
Event 12/31/2024
|
||
| Camber Capital Management LP | 0% | |||
| Stephen DuBois | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 7 | 5.93 k | $43.1k |
| 2025 Q4 | 5 | 1.37 k | $7.73k |
| 2025 Q3 | 5 | 12.5 k | $77.1k |
| 2025 Q2 | 4 | 996 | $4.85k |
| 2025 Q1 | 3 | 478 | $1.77k |
| 2024 Q4 | 1 | 7.00 | $28 |
| 2024 Q3 | 1 | 7.00 | $49 |
| 2024 Q2 | 1 | 7.00 | $40 |
| 2024 Q1 | 1 | 6.00 | $80 |
| 2023 Q4 | 1 | 6.00 | $37 |
| 2023 Q3 | 1 | 6.00 | $15 |
| 2023 Q2 | 2 | 72.0 | $377 |
| 2023 Q1 | 2 | 72.0 | $341 |
| 2022 Q4 | 2 | 10.8 k | $58.1k |
| 2022 Q3 | 62 | 63.5 M | $33.4M |
| 2022 Q2 | 69 | 64.2 M | $39.5M |
| 2022 Q1 | 78 | 69.3 M | $83.2M |
| 2021 Q4 | 83 | 75.6 M | $132M |
| 2021 Q3 | 94 | 77.0 M | $184M |
| 2021 Q2 | 94 | 80.2 M | $293M |
| 2021 Q1 | 108 | 79.1 M | $438M |
| 2020 Q4 | 78 | 54.6 M | $414M |
| 2020 Q3 | 62 | 25.5 M | $52.5M |
| 2020 Q2 | 67 | 26.8 M | $79.1M |
| 2020 Q1 | 72 | 19.6 M | $46.9M |
| 2019 Q4 | 72 | 19.9 M | $88.5M |
| 2019 Q3 | 70 | 32.1 M | $332M |
| 2019 Q2 | 75 | 21.4 M | $129M |
| 2019 Q1 | 77 | 17.1 M | $157M |
| 2018 Q4 | 78 | 24.2 M | $648M |
| 2018 Q3 | 77 | 18.6 M | $879M |
| 2018 Q2 | 64 | 17.3 M | $617M |
| 2018 Q1 | 58 | 15.9 M | $119M |